<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03719456</url>
  </required_header>
  <id_info>
    <org_study_id>AE 2394</org_study_id>
    <nct_id>NCT03719456</nct_id>
  </id_info>
  <brief_title>Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm</brief_title>
  <official_title>Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim at this study to prospectively assess procedure-related outcomes after
      RIRS for renal calculi less than 20 mm, including stone free rate (SFR), predictors of
      successful outcome, complications types/rate, readmission rate and the need of auxiliary
      procedures. In addition, patient-reported outcomes after this modality of intervention are
      going to be assessed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stone free rate (SFR)</measure>
    <time_frame>It will be assessed by non contrast computed tomography for the participants one month after the procedure</time_frame>
    <description>stone free rate after the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Predictors of operative time of the procedure</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>Predictors of operative time of the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Post-operative complications using modified Dindo-Clavian grading system</measure>
    <time_frame>within 30 days after the procedure</time_frame>
    <description>- Post-operative complications (Type/rate/predictors) using modified Dindo-Clavian grading system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-operative clinical judgment of the surgeon on stone free status using flouroscopy and visual scanning of pelvicalyceal system and its relation to post-operative NCCT.</measure>
    <time_frame>Post operative day 1 after the procedure</time_frame>
    <description>- Intra-operative surgeon perspective about procedure outcome and its relation to post-operative NCCT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Patient -reported outcomes about post operative pain using visual analogue scale</measure>
    <time_frame>within 3 months after the procedure</time_frame>
    <description>• Post-operative pain: Postoperative pain will be evaluated in all patients by using visual analogue scale (VAS). The impact of patient-related, stone-related and procedure-related factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient -reported outcomes about General impression on the procedure using Freiburg Index of patient Satisfaction (FIPS).</measure>
    <time_frame>within 3 months after the procedure</time_frame>
    <description>Patient -reported outcomes about General impression on the procedure using Freiburg Index of patient Satisfaction (FIPS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patient-reported outcomes using patient-reported outcomes measurements information system (PROMIS)</measure>
    <time_frame>within 3 months after the procedure</time_frame>
    <description>Procedure impact on improvement in patient-reported outcomes measurements information system (PROMIS): PROMIS is a National Institute of Health (NIH) validated system to assess patient quality of life. The PROMIS survey consists of 43 questions assessing the following categories: anxiety/fear, depression/ sadness, fatigue, pain interference, physical function, and sleep disturbance.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Renal Stone</condition>
  <arm_group>
    <arm_group_label>Flexible ureteroscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Retrograde Intrarenal Surgery</intervention_name>
    <arm_group_label>Flexible ureteroscope</arm_group_label>
    <other_name>Flexible ureteroscope</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ability to give informed consent.

          2. Stone criteria:

               -  Less than 20 mm.

               -  Infectious stone.

               -  Growing stone on follow-up.

          3. Kidney criteria:

               -  Obstructing stone causing hydronephrosis.

               -  Solitary kidney or bilateral renal stones.

          4. Patients criteria:

               -  Age ≥18 years.

               -  Symptomatic stone causing pain or hematuria.

               -  Patient comorbidity omitting other modalities as bleeding diathesis or skeletal
                  deformities.

               -  Patient preference or patients' social situation concerning profession or amount
                  of travel

        Exclusion Criteria:

          1. Inability to give informed consent.

          2. Stone criteria:

               -  More than 20 mm.

               -  Peripheral calyceal asymptomatic stone static in size on follow-up.

               -  Unsuitable/failure of initial treatment modalities (oral dissolution therapy-SWL)
                  for stones less than 20 mm.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amr A Elsawy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Urology and Nephrology Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amr A Elsawy, MD</last_name>
    <phone>0502202222</phone>
    <email>amrelsawy.unc@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Urology and Nephrology Center</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr A. Elsawy, MD</last_name>
      <phone>0020502202222</phone>
      <email>amrelsawy.unc@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Amr A Elsawy</name>
      <address>
        <city>Al Manşūrah</city>
        <zip>35516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr A Elsawy, MD</last_name>
      <phone>0502202222</phone>
      <email>amrelsawy.unc@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Amr A. El-Sawy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>October 24, 2018</last_update_submitted>
  <last_update_submitted_qc>October 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Abdel-Lateif El-Sawy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Renal stone</keyword>
  <keyword>Calculi</keyword>
  <keyword>Retrograde Intrarenal Surgery</keyword>
  <keyword>Flexible ureteroscope</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

